0001243233-17-000002.txt : 20170411 0001243233-17-000002.hdr.sgml : 20170411 20170411145320 ACCESSION NUMBER: 0001243233-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170411 DATE AS OF CHANGE: 20170411 EFFECTIVENESS DATE: 20170411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Geom Therapeutics, Inc. CENTRAL INDEX KEY: 0001702693 IRS NUMBER: 811291870 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-284519 FILM NUMBER: 17755775 BUSINESS ADDRESS: STREET 1: 826A VALLEJO STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94133 BUSINESS PHONE: 415-533-3236 MAIL ADDRESS: STREET 1: 826A VALLEJO STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94133 D 1 primary_doc.xml X0707 D LIVE 0001702693 Geom Therapeutics, Inc. 826A Vallejo Street SAN FRANCISCO CA CALIFORNIA 94133 415-533-3236 DELAWARE None None Corporation true 2015 Dirk Thye c/o Geom Therapeutics, Inc. 826A Vallejo Street San Francisco CA CALIFORNIA 94133 Executive Officer Director Dov Goldstein c/o Geom Therapeutics, Inc. 826A Vallejo Street San Francisco CA CALIFORNIA 94133 Director Yong-Zu Kim c/o Geom Therapeutics, Inc. 826A Vallejo Street San Francisco CA CALIFORNIA 94133 Director Sejin Park c/o Geom Therapeutics, Inc. 826A Vallejo Street San Francisco CA CALIFORNIA 94133 Director Cooper Collins c/o Geom Therapeutics, Inc. 826A Vallejo Street San Francisco CA CALIFORNIA 94133 Director Biotechnology Decline to Disclose 06b false 2017-03-09 false true true Series A Preferred Stock and Common Stock issuable upon conversion false 0 4500000 4355000 145000 false 17 0 0 0 false Geom Therapeutics, Inc. /s/ Brendan Hannah Brendan Hannah Secretary 2017-04-08